Affiliation:
1. Geriatric Unit, Graduate School of Medicine Kyoto University Kyoto Japan
2. Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine Kyoto University Kyoto Japan
3. Department of Neurosurgery Shiga University of Medical Science Otsu Japan
Abstract
In aging societies, social and economic burdens of aging‐related diseases are increasing significantly. Senotherapy, which targets aging by eliminating senescent cells (senolytics) or removing sources of chronic inflammation (senostatics), are proposed as novel strategies for aging‐related diseases. Aged or frail people suffer a decline of tissue reserve capacity during aging. Resilience, which is much reduced in older people, is essential for recovery from diseases, stresses or crises. Impaired resilience is one of the reasons why aged people experience a gradual waning of their daily activity and an increase of multimorbidity. Calorie restriction results in senostatic alleviation of chronic inflammation, whereas senolytic drugs induce apoptosis of senescent cells, which exacerbate aging by excreting inflammatory factors. Thus, both senolytics and senostatics are expected to reduce sterile inflammation, originating from senescent cells. Geriatr Gerontol Int 2024; ••: ••–••.